Event Highlights
News from Bayer
October 05, 2022
Bayer completes sale of its Environmental Science Professional business to Cinven
September 08, 2022
Not intended for U.S. and UK Media
Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients
September 02, 2022
Not intended for U.S. and UK Media
Kerendia™ (finerenone) receives updated label in the U.S. to include findings from Phase III FIGARO-DKD cardiovascular outcomes study
Discover More Investor Resources
